[Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases]
| Autor: | Audrey, Gering, Laurent, Grange, Céline, Villier, Anne, Woeller, Michel, Mallaret |
|---|---|
| Přispěvatelé: | GREPI, Techniques de l'Ingénierie Médicale et de la Complexité - Informatique, Mathématiques et Applications, Grenoble - UMR 5525 (TIMC-IMAG), VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF), Hospital Hygiene Unit, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble |
| Jazyk: | francouzština |
| Rok vydání: | 2007 |
| Předmět: |
Male
MESH: Aged MESH: Humans MESH: Jaw Diseases Bone Density Conservation Agents Diphosphonates MESH: Diphosphonates Osteonecrosis MESH: Bone and Bones MESH: Osteonecrosis Bone and Bones MESH: Male MESH: Bone Density Conservation Agents [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system Humans Female MESH: Female Jaw Diseases Aged |
| Zdroj: | Thérapie Thérapie, EDP Sciences, 2007, 62 (1), pp.49-54. ⟨10.2515/therapie:2007003⟩ |
| ISSN: | 0040-5957 1958-5578 |
| DOI: | 10.2515/therapie:2007003⟩ |
| Popis: | International audience; Osteonecrosis of the jaws associated with the use of bisphosphonates (alendronate, pamidronate, risedronate et zoledronate) are described as an avascular necrosis. We have listed 184 cases of bisphosphonates-associated osteonecrosis of the maxillary in the literature. Many mechanisms are discussed in bisphosphonates-associated osteonecrosis: a disturbing bone turnover, an accumulation of bone's microdamage or an antiangiogenic effect. Other risk factors seem however to be involved: cancer, chemotherapy, glucocorticoids, infection and renal insufficiency. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|